Please assess the completion status of the following clinical trial:

Trial Title: 18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Must be able to tolerate PET/CT (i.e. not claustrophobic and able to remain supine)~* No restrictions based on gender or racial/ethnic background~Exclusion Criteria:~* Women of childbearing age will have to undergo a pregnancy test that will be provided free of charge

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Basic science (18F-clofarabine biodistribution) (Type: None): Patients receive 18F-clofarabine IV and undergo PET/CT scan at baseline and 2-4 weeks after completion of immunotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).